Skip to main content
SpringerLink
Log in
Book cover

Postmenopausal Diseases and Disorders pp 53–78Cite as

Human Papillomavirus Infection and Cancer Risk in Peri- and Postmenopausal Women

  • Chapter
  • First Online:

Abstract

Human papillomavirus (HPV) infection is a necessary cause of cervical cancer. Contrarily to most preinvasive cervical lesions, the majority of cancers occur in the perimenopause or early after the menopause. Nevertheless, around 15% of cervical cancers occur after 65 years old. There are data suggesting that screening beyond this age can decrease cervical cancer-associated mortality. Screening in postmenopausal women is better accomplished with the use of high-risk HPV tests. Atrophy with thinning of the epithelium and regression of the squamous cellular junction to the endocervix can make colposcopy in postmenopausal women a true challenge.

Prevalence of HPV infection decreases after the age of 25–30 years old, keeping stable from then on. In some countries, a later peak can be noticed in the fifth or six decade of life. Postmenopausal women are still at risk of acquiring new HPV infections, as well as of having reactivation of latent ones.

The burden of disease associated with HPV is not limited to the cervix. It is also responsible for a significant number of vulvar, vaginal, anal, and even oropharyngeal cancers—beside benign and preinvasive disease.

While HPV vaccination will totally change the epidemiology of HPV infection, vaccinating older women has a very limited role.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi FE, et al. A review of human carcinogens—Part B: biological agents. Lancet Oncol. 2009;10(4):321–2.

    Article  PubMed  Google Scholar 

  2. Denis F, Hanz S, Alain S. Clairance, persistance et récidive de l’infection à Papillomavirus. Gynecol Obstet Fertil. 2008;36(4):430–40.

    Article  CAS  PubMed  Google Scholar 

  3. Roehr B. Presence of HPV in later life may represent reactivation, not reinfection. BMJ. 2012;345:e8517.

    Article  PubMed  Google Scholar 

  4. Syrjänen K, Hakama M, Saarikoski S, Väyrynen M, Yliskoski M, Syrjänen S, et al. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis. 1990;17(1):15–9.

    Article  PubMed  Google Scholar 

  5. Mariani L, Preti M, Cristoforoni P, Stigliano CM, Perino A. Overview of the benefits and potential issues of the nonavalent HPV vaccine. Int J Gynaecol Obstet. 2017;136(3):258–65.

    Article  PubMed  Google Scholar 

  6. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–99.

    Article  PubMed  Google Scholar 

  7. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Brown DR, Weaver B. Human papillomavirus in older women: new infection or reactivation? J Infect Dis. 2013;207(2):211–2.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gravitt PE, Rositch AF, Silver MI, Marks MA, Chang K, Burke AE, et al. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. J Infect Dis. 2013;207(2):272–80.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gonzalez P, Hildesheim A, Rodriguez AC, Schiffman M, Porras C, Wacholder S, et al. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3044–54.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Franceschi S, Herrero R, Clifford GM, Snijders PJF, Arslan A, Anh PTH, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006;119(11):2677–84.

    Article  CAS  PubMed  Google Scholar 

  12. Grainge MJ, Seth R, Guo L, Neal KR, Coupland C, Vryenhoef P, et al. Cervical human papillomavirus screening among older women. Emerg Infect Dis. 2005;11(11):1680–5.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is agedependent. Int J Cancer. 1993;53(6):919–23.

    Article  CAS  PubMed  Google Scholar 

  14. Gyllensten U, Gustavsson I, Lindell M, Wilander E. Primary high-risk HPV screening for cervical cancer in post-menopausal women. Gynecol Oncol. 2012;125(2):343–5.

    Article  PubMed  Google Scholar 

  15. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus–positive women. J Natl Cancer Inst. 2005;97(8):577–86.

    Article  PubMed  Google Scholar 

  16. Petry KU, Horn J, Luyten A, Mikolajczyk RT. Punch biopsies shorten time to clearance of high-risk human papillomavirus infections of the uterine cervix. BMC Cancer. 2018;18(1):318.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bekos C, Schwameis R, Heinze G, Gärner M, Grimm C, Joura E, et al. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis. Sci Rep. 2018;8(1):6383.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Olsen NJ, Kovaks WJ. Gonadal steroids and immunity. Endocr Rev. 1996;17(4):369–84.

    CAS  PubMed  Google Scholar 

  19. Sakiani S, Olsen NJ, Kovacs WJ. Gonadal steroids and humoral immunity. Nat Rev Endocrinol. 2013;9(1):56–62.

    Article  CAS  PubMed  Google Scholar 

  20. Gameiro CM, Romão F, Castelo-Branco C. Menopause and aging: changes in the immune system—a review. Maturitas. 2010;67(4):316–20.

    Article  CAS  PubMed  Google Scholar 

  21. Stanley MA, Sterling JC. Host responses to infection with human papillomavirus. Curr Probl Dermatol. 2014;45:58–74.

    Article  PubMed  Google Scholar 

  22. Scherer EM, Smith RA, Gallego DF, Carter JJ, Wipf GC, Hoyos M, et al. A single human papillomavirus vaccine dose improves B cell memory in previously infected subjects. EBioMedicine. 2016;10:55–64.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102(5):315–24.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ramachandran B. Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis. Endocr Relat Cancer. 2017;24(4):R99–108.

    Article  CAS  PubMed  Google Scholar 

  25. Ferenczy A, Gelfand M, Franco E, Mansour N. Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstet Gynecol. 1997;90(1):7–11.

    Article  CAS  PubMed  Google Scholar 

  26. Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, et al. The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort. PLoS One. 2016;11(1):e0147029.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Boonyanurak P, Panichakul S, Wilawan K. Prevalence of high-risk human papillomavirus infection (HPV) and correlation with postmenopausal hormonal therapy in Thai women aged more than 45 years old. J Med Assoc Thai. 2010;93(1):9–16.

    PubMed  Google Scholar 

  28. Munger K. Are selective estrogen receptor modulators (SERMs) a therapeutic option for HPV-associated cervical lesions and cancers? Am J Pathol. 2014;184(2):358–61.

    Article  CAS  PubMed  Google Scholar 

  29. Rhodes HE, Chenevert L, Munsell M. Vaginal intraepithelial neoplasia (VaIN 2/3). J Low Genit Tract Dis. 2014;18(2):115–21.

    Article  PubMed  Google Scholar 

  30. Smith EM, Levy BT, Ritchie JM, Jia J, Wang D, Haugen TH, et al. Is use of hormone replacement therapy associated with increased detection of human papillomavirus and potential risk of HPV-related genital cancers? Eur J Cancer Prev. 2002;11(3):295–305.

    Article  CAS  PubMed  Google Scholar 

  31. Clarke MA, Rodriguez AC, Gage JC, Herrero R, Hildesheim A, Wacholder S, et al. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis. 2012;12:33.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kero K, Rautava J, Syrjänen K, Grenman S, Syrjänen S. Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection. Eur J Clin Microbiol Infect Dis. 2017;36(11):2215–9.

    Article  CAS  PubMed  Google Scholar 

  33. Vieira-Baptista P, Lima-Silva J, Pinto C, Saldanha C, Beires J, Martinez-de-Oliveira J, et al. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities. Eur J Clin Microbiol Infect Dis. 2016;35:657–64.

    Article  CAS  PubMed  Google Scholar 

  34. Hoffmann JN, You HM, Hedberg EC, Jordan JA, McClintock MK. Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States. J Gerontol Ser B Psychol Sci Soc Sci. 2014;69(Suppl 2):S205–14.

    Article  Google Scholar 

  35. Zhang H, Lu J, Lu Y, Cai Q, Liu H, Xu C. Cervical microbiome is altered in cervical intraepithelial neoplasia after loop electrosurgical excision procedure in China. Sci Rep. 2018;8(1):4923.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5:CD009069.

    PubMed  Google Scholar 

  37. Schwarz TF, Galaj A, Spaczynski M, Wysocki J, Kaufmann AM, Poncelet S, et al. Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age. Cancer Med. 2017;6(11):2723–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Faubion SS, Larkin LC. Immunizations for adult women. Menopause. 2016;23(12):1345–7.

    Article  PubMed  Google Scholar 

  39. Preti M. VIN usual type—from the past to the future. Ecancermedicalscience. 2015;9:531.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Parker KH, Kemp TJ, Pan Y, Yang Z, Giuliano AR, Pinto LA. Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® sponges. Vaccine. 2018;36(19):2705–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Pinto LA, Kemp TJ, Torres BN, Isaacs-Soriano K, Ingles D, Abrahamsen M, et al. Quadrivalent human papillomavirus (HPV) vaccine induces HPV-specific antibodies in the Oral cavity: results from the mid-adult male vaccine trial. J Infect Dis. 2016;214(8):1276–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-tieulent J, Jemal A. Global cancer statistics, 2012. CA A Cancer J Clin. 2015;65(2):87–108.

    Article  Google Scholar 

  43. Garland SM, Giuliano A, Brotherton J, Moscicki AB, Stanley M, Kaufmann AM, et al. IPVS statement moving towards elimination of cervical cancer as a public health problem. Papillomavirus Res. 2018;5:87–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19(2):319–24.

    PubMed  PubMed Central  Google Scholar 

  45. Franceschi S, Clifford GM, Baussano I. Options for design of real-world impact studies of single-dose vaccine schedules. Vaccine. 2018;36(32 Pt A):4816–22.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Harper DM, Vierthaler SL. Next generation cancer protection: the bivalent HPV vaccine for females. ISRN Obstet Gynecol. 2011;2011:1–20.

    Article  Google Scholar 

  47. Oakley F, Desouki MM, Pemmaraju M, Gargano JM, Markowitz LE, Steinau M, et al. Trends in high-grade cervical Cancer precursors in the human papillomavirus vaccine era. Am J Prev Med. 2018;55(1):19–25.

    Article  PubMed  Google Scholar 

  48. Halford J, Walker K-A, Duhig J. A review of histological outcomes from peri-menopausal and post-menopausal women with a cytological report of possible high grade abnormality: an alternative management strategy for these women. Pathology. 2010;42(1):23–7.

    Article  PubMed  Google Scholar 

  49. Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N. Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptiveuse patients. Cancer. 2008;114(6):481–8.

    Article  PubMed  Google Scholar 

  50. Gilani SM, Mazzara PF. Cytohistologic correlation in premenopausal and postmenopausal women. Acta Cytol. 2013;57(6):575–80.

    Article  PubMed  Google Scholar 

  51. Bornstein J, Sideri M, Tatti S, Walker P, Prendiville W, Haefner HK, et al. 2011 terminology of the vulva of the International Federation for Cervical Pathology and Colposcopy. J Low Genit Tract Dis. 2012;16(3):290–5.

    Article  PubMed  Google Scholar 

  52. Cuzick J, Clavel C, Petry K-U, Meijer CJLM, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119(5):1095–101.

    Article  CAS  PubMed  Google Scholar 

  53. Piccoli R, Mandato VD, Lavitola G, Acunzo G, Bifulco G, Tommaselli GA, et al. Atypical squamous cells and low squamous intraepithelial lesions in postmenopausal women: implications for management. Eur J Obstet Gynecol Reprod Biol. 2008;140(2):269–74.

    Article  PubMed  Google Scholar 

  54. Vieira-Baptista P, Sousa C, Saldanha C, Fonseca-Moutinho JA. Consenso da ASCCP 2012—o que traz de novo e implicações para o dia-a-dia. Acta Obs Ginecol Port. 2013;7(4):241–8.

    Google Scholar 

  55. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121(4):829–46.

    Article  PubMed  Google Scholar 

  56. Zhao C, Austin R. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone. Gynecol Oncol. 2007;107(2):231–5.

    Article  CAS  PubMed  Google Scholar 

  57. Cuzick J, Thomas Cox J, Zhang G, Einstein MH, Stoler M, Trupin S, et al. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. Int J Cancer. 2013;132(4):959–66.

    Article  CAS  PubMed  Google Scholar 

  58. Practice Bulletin No. 168. Obstet Gynecol. 2016;128(4):e111–30.

    Google Scholar 

  59. Rustagi AS, Kamineni A, Weinmann S, Reed SD, Newcomb P, Weiss NS. Cervical screening and cervical Cancer death among older women: a population-based, case-control study. Am J Epidemiol. 2014;179(9):1107–14.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Andrae B, Andersson TM-L, Lambert PC, Kemetli L, Silfverdal L, Strander B, et al. Screening and cervical cancer cure: population based cohort study. BMJ. 2012;344:e900.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. Am J Obstet Gynecol. 2010;203(5):481.e1–9.

    Article  Google Scholar 

  62. Boulanger JC, Gondry J, Verhoest P, Capsie C, Najas S. Treatment of CIN after menopause. Eur J Obstet Gynecol Reprod Biol. 2001;95(2):175–80.

    Article  CAS  PubMed  Google Scholar 

  63. Richards A, Dalrymple C. Abnormal cervicovaginal cytology, unsatisfactory colposcopy and the use of vaginal estrogen cream: an observational study of clinical outcomes for women in low estrogen states. J Obstet Gynaecol Res. 2015;41(3):440–4.

    Article  PubMed  Google Scholar 

  64. Makkar B, Batra S, Gandhi G, Zutshi V, Goswami D. Vaginal misoprostol versus vaginal estradiol in overcoming unsatisfactory colposcopy. Gynecol Obstet Investig. 2014;77(3):176–9.

    Article  CAS  Google Scholar 

  65. Aggarwal R, Suneja A, Agarwal N, Mishra K. Role of misoprostol in overcoming an unsatisfactory colposcopy: a randomized double-blind placebo-controlled clinical trial. Gynecol Obstet Investig. 2006;62(2):115–20.

    Article  CAS  Google Scholar 

  66. Thanapprapasr D, Wilailak S, Ayudhya NIN, Lertkhachonsuk A-A, Likittanasombut P, Chittithaworn S, et al. Can vaginal misoprostol effectively increase rate of a satisfactory colposcopy? A randomized double-blind placebo-controlled trial. Jpn J Clin Oncol. 2010;40(3):203–7.

    Article  PubMed  Google Scholar 

  67. Boardman LA, Meinz H, Steinhoff MM, Heber WW, Blume J. A randomized trial of the sleeved cytobrush and the endocervical curette. Obstet Gynecol. 2003;101(3):426–30.

    PubMed  Google Scholar 

  68. Tate K, Strickland J. A randomized controlled trial to evaluate the use of the endocervical brush after endocervical curettage. Obstet Gynecol. 1997;90(5):715–7.

    Article  CAS  PubMed  Google Scholar 

  69. Driggers RW, Zahn CM. To ECC or not to ECC: the question remains. Obstet Gynecol Clin North Am. 2008;35(4):583–97.

    Article  PubMed  Google Scholar 

  70. Irvin W, Flora S, Andersen W, Stoler M, Taylor P, Rice L. Endocervical curettage. Does it contribute to the management of patients with abnormal cervical cytology? J Reprod Med. 2004;49(1):1–7.

    PubMed  Google Scholar 

  71. Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2013;(6):CD001318.

    Google Scholar 

  72. Fine BA, Feinstein GI, Sabella V. The pre- and postoperative value of endocervical curettage in the detection of cervical intraepithelial neoplasia and invasive cervical cancer. Gynecol Oncol. 1998;71(1):46–9.

    Article  CAS  PubMed  Google Scholar 

  73. Hasegawa K, Torii Y, Kato R, Udagawa Y, Fukasawa I. The problems of cervical conization for postmenopausal patients. Eur J Gynaecol Oncol. 2016;37(3):327–31.

    CAS  PubMed  Google Scholar 

  74. Chen Y, Lu H, Wan X, Lv W, Xie X. Factors associated with positive margins in patients with cervical intraepithelial neoplasia grade 3 and postconization management. Int J Gynecol Obstet. 2009;107(2):107–10.

    Article  Google Scholar 

  75. Chambo Filho A, Garbeloto E, Guarconi JRA, Partele MP. Positive endocervical margins at conization: repeat conization or colposcopic follow-up? A retrospective study. J Clin Med Res. 2015;7(7):540–4.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Binyamin L, Segev M, Peled Y, Krissi H, Sabah G, Raban O, et al. Simple hysterectomy for residual cervical intraepithelial neoplasm. J Low Genit Tract Dis. 2018;22(2):126–8.

    Article  PubMed  Google Scholar 

  77. González Bosquet E, Torres A, Busquets M, Esteva C, Muñoz-Almagro C, Lailla JM. Prognostic factors for the development of vaginal intraepithelial neoplasia. Eur J Gynaecol Oncol. 2008;29(1):43–5.

    PubMed  Google Scholar 

  78. Arbyn M, Redman CWE, Verdoodt F, Kyrgiou M, Tzafetas M, Ghaem-Maghami S, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017;18(12):1665–79.

    Article  PubMed  Google Scholar 

  79. Tanaka Y, Ueda Y, Kakuda M, Kubota S, Matsuzaki S, Iwamiya T, et al. Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases. Int J Clin Oncol. 2017;22(5):921–6.

    Article  PubMed  Google Scholar 

  80. Penna C, Fambrini M, Fallani MG, Pieralli A, Scarselli G, Marchionni M. Laser CO2 conization in postmenopausal age: risk of cervical stenosis and unsatisfactory follow-up. Gynecol Oncol. 2005;96(3):771–5.

    Article  PubMed  Google Scholar 

  81. Gosvig CF, Huusom LD, Andersen KK, Duun-Henriksen AK, Frederiksen K, Iftner A, et al. Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization. Int J Cancer. 2015;137(12):2927–33.

    Article  CAS  PubMed  Google Scholar 

  82. Ceballos KM, Lee M, Cook DA, Smith LW, Gondara L, Krajden M, et al. Post–loop electrosurgical excision procedure high-risk human papillomavirus testing as a test of cure. J Low Genit Tract Dis. 2017;21(4):284–8.

    Article  PubMed  Google Scholar 

  83. Cubie HA, Canham M, Moore C, Pedraza J, Graham C, Cuschieri K. Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H). J Clin Pathol. 2014;67(6):458–63.

    Article  CAS  PubMed  Google Scholar 

  84. RMF E, DWE R, IntHout J, WJG M, LFAG M, Bulten J, et al. Long-lasting increased risk of human papillomavirus–related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study. J Clin Oncol. 2017;35(22):2542–50.

    Article  Google Scholar 

  85. Zhang J, Chang X, Qi Y, Zhang Y, Zhang S. A retrospective study of 152 women with vaginal intraepithelial neoplasia. Int J Gynecol Obstet. 2016;133(1):80–3.

    Article  Google Scholar 

  86. Sillman FH, Fruchter RG, Chen YS, Camilien L, Sedlis A, McTigue E. Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management. Am J Obstet Gynecol. 1997;176(1 Pt 1):93–9.

    Article  CAS  PubMed  Google Scholar 

  87. Dodge JA, Eltabbakh GH, Mount SL, Walker RP, Morgan A. Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol. 2001;83(2):363–9.

    Article  CAS  PubMed  Google Scholar 

  88. Diakomanolis E, Stefanidis K, Rodolakis A, Haidopoulos D, Sindos M, Chatzipappas I, et al. Vaginal intraepithelial neoplasia: report of 102 cases. Eur J Gynaecol Oncol. 2002;23(5):457–9.

    CAS  PubMed  Google Scholar 

  89. Sopracordevole F, Barbero M, Clemente N, Fallani MG, Cattani P, Agarossi A, et al. Colposcopic patterns of vaginal intraepithelial neoplasia. Eur J Cancer Prev. 2018;27(2):152–7.

    Article  PubMed  Google Scholar 

  90. Ratnavelu N, Patel A, Fisher A, Galaal K, Cross P, Naik R. High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat? BJOG. 2013;120(7):887–93.

    Article  CAS  PubMed  Google Scholar 

  91. Tainio K, Jakobsson M, Louvanto K, Kalliala I, Paavonen J, Nieminen P, et al. Randomised trial on treatment of vaginal intraepithelial neoplasia-imiquimod, laser vaporisation and expectant management. Int J Cancer. 2016;139(10):2353–8.

    Article  CAS  PubMed  Google Scholar 

  92. Sopracordevole F, Barbero M, Clemente N, Fallani MG, Cattani P, Agarossi A, et al. High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Eur Rev Med Pharmacol Sci. 2016;20(5):818–24.

    CAS  PubMed  Google Scholar 

  93. Sinno AK, Saraiya M, Thompson TD, Hernandez BY, Goodman MT, Steinau M, et al. Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstet Gynecol. 2014;123(4):817–21.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Lilic V, Lilic G, Filipovic S, Visnjic M, Zivadinovic R. Primary carcinoma of the vagina. J BUON. 2010;15(2):241–7.

    CAS  PubMed  Google Scholar 

  95. Pride GL, Buchler DA. Carcinoma of vagina 10 or more years following pelvic irradiation therapy. Am J Obstet Gynecol. 1977;127(5):513–7.

    Article  CAS  PubMed  Google Scholar 

  96. Dominiak-Felden G, Cohet C, Atrux-Tallau S, Gilet H, Tristram A, Fiander A. Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, healthrelated quality of life study in the UK. BMC Public Health. 2013;13(1):1065.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Gunter J. Genital and perianal warts: new treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol. 2003;189(3 Suppl):S3–11.

    Article  PubMed  Google Scholar 

  98. Mayeaux EJ, Dunton C. Modern management of external genital warts. J Low Genit Tract Dis. 2008;12(3):185–92.

    Article  PubMed  Google Scholar 

  99. Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39.

    Article  PubMed  PubMed Central  Google Scholar 

  100. van Beurden M, van der Vange N, de Craen AJ, Tjong-A-Hung SP, ten Kate FJ, ter Schegget J, et al. Normal findings in vulvar examination and vulvoscopy. Br J Obstet Gynaecol. 1997;104(3):320–4.

    Article  PubMed  Google Scholar 

  101. Chang L, Ci P, Shi J, Zhai K, Feng X, Colombara D, et al. Distribution of genital wart human papillomavirus genotypes in China: a multi-center study. J Med Virol. 2013;85(10):1765–74.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Howell-Jones R, Soldan K, Wetten S, Mesher D, Williams T, Gill ON, et al. Declining genital warts in young women in England associated with HPV 16/18 vaccination: an ecological study. J Infect Dis. 2013;208(9):1397–403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Vulvar cancer—cancer stat facts. https://seer.cancer.gov/statfacts/html/vulva.html.

  104. Kurman RJ, American Registry of Pathology, Armed Forces Institute of Pathology (U.S.). Tumors of the cervix, vagina, and vulva. American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2010. p. 431.

    Google Scholar 

  105. Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, et al. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer. 2008;113(10 Suppl):2865–72.

    Article  PubMed  Google Scholar 

  106. Buttmann-Schweiger N, Klug SJ, Luyten A, Holleczek B, Heitz F, Du Bois A, et al. Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis. PLoS One. 2015;10(5):e0128073.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Baandrup L, Varbo A, Munk C, Johansen C, Frisch M, Kjaer SK. In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study. Gynecol Oncol. 2011;122(1):45–9.

    Article  CAS  PubMed  Google Scholar 

  108. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107(5):1018–22.

    Article  PubMed  Google Scholar 

  109. Bodelon C, Madeleine MM, Voigt LF, Weiss NS. Is the incidence of invasive vulvar cancer increasing in the United States? Cancer Causes Control. 2009;20(9):1779–82.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Barlow EL, Kang Y-J, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since 1982. Int J Gynecol Cancer. 2015;25(9):1683–9.

    Article  PubMed  Google Scholar 

  111. Bornstein J, Bogliatto F, Haefner HK, Stockdale CK, Preti M, Bohl TG, Reutter J, ISSVD Terminology Committee. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. Obstet Gynecol. 2016;127(2):264–8.

    Google Scholar 

  112. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med. 2005;50(11):807–10.

    PubMed  Google Scholar 

  113. Bornstein J, Bogliatto F, Haefner HK, Stockdale CK, Preti M, Bohl TG, et al. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. J Low Genit Tract Dis. 2016;20(1):11–4.

    Article  PubMed  Google Scholar 

  114. De Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450–61.

    Article  PubMed  Google Scholar 

  115. van de Nieuwenhof HP, Massuger LFAG, van der Avoort IAM, Bekkers RLM, Casparie M, Abma W, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45(5):851–6.

    Article  PubMed  Google Scholar 

  116. de Bie RP, van de Nieuwenhof HP, Bekkers RLM, Melchers WJG, Siebers a G, Bulten J, et al. Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities. Br J Cancer. 2009;101(1):27–31.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Preti M, Bucchi L, Ghiringhello B, Privitera S, Frau V, Corvetto E, et al. Risk factors for unrecognized invasive carcinoma in patients with vulvar high-grade squamous intraepithelial lesion at vulvoscopy-directed biopsy. J Gynecol Oncol. 2017;28(4):e27.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Bornstein J, Kaufman RH, Adam E, Adler-Storthz K. Multicentric intraepithelial neoplasia involving the vulva. Clinical features and association with human papillomavirus and herpes simplex virus. Cancer. 1988;62(8):1601–4.

    Article  CAS  PubMed  Google Scholar 

  119. McAlpine JN, Kim SY, Akbari A, Eshragh S, Reuschenbach M, von Knebel Doeberitz M, et al. HPV-independent differentiated vulvar intraepithelial neoplasia (dVIN) is associated with an aggressive clinical course. Int J Gynecol Pathol. 2017;36(6):507–16.

    Article  PubMed  Google Scholar 

  120. American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice, American Society for Colposcopy and Cervical Pathology (ASCCP). Committee opinion no. 675. Obstet Gynecol. 2016;128(4):e178–82.

    Article  CAS  Google Scholar 

  121. Kokka F, Singh N, Faruqi A, Gibbon K, Rosenthal AN. Is differentiated vulval intraepithelial neoplasia the precursor lesion of human papillomavirus-negative vulval squamous cell carcinoma? Int J Gynecol Cancer. 2011;21(7):1297–305.

    Article  PubMed  Google Scholar 

  122. Preti M, Scurry J, Marchitelli CE, Micheletti L. Vulvar intraepithelial neoplasia. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1051–62.

    Article  PubMed  Google Scholar 

  123. Terlou A, Van Seters M, Ewing PC, Aaronson NK, Gundy CM, Heijmans-Antonissen C, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial. Gynecol Oncol. 2011;121(1):157–62.

    Article  CAS  PubMed  Google Scholar 

  124. Hurt CN, Jones SEF, Madden T, Fiander A, Nordin AJ, Naik R, et al. Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN). BJOG. 2018;25(9):1171–7.

    Article  CAS  Google Scholar 

  125. Dellinger TH, Hakim AA, Lee SJ, Wakabayashi MT, Morgan RJ, Han ES. Surgical management of vulvar cancer. J Natl Compr Cancer Netw. 2017;15(1):121–8.

    Article  Google Scholar 

  126. Micheletti L, Preti M. Surgery of the vulva in vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1074–87.

    Article  PubMed  Google Scholar 

  127. Baiocchi G, Rocha RM. Vulvar cancer surgery. Curr Opin Obstet Gynecol. 2014;26(1):9–17.

    Article  PubMed  Google Scholar 

  128. Preti M, Rouzier R, Mariani L, Wilkinson EJ. Superficially invasive carcinoma of the vulva: diagnosis and treatment. Clin Obstet Gynecol. 2005;48(4):862–8.

    Article  PubMed  Google Scholar 

  129. Zhou J, Shan G. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis. Curr Med Res Opin. 2016;32(6):1121–30.

    Article  CAS  PubMed  Google Scholar 

  130. Luchini C, Nottegar A, Solmi M, Sergi G, Manzato E, Capelli P, et al. Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: a systematic review and meta-analysis. Surg Oncol. 2016;25(1):60–5.

    Article  PubMed  Google Scholar 

  131. Hudson CN, Shulver H, Lowe DC. The surgery of “inguino-femoral” lymph nodes: is it adequate or excessive? Int J Gynecol Cancer. 2004;14(5):841–5.

    CAS  PubMed  Google Scholar 

  132. Te Grootenhuis NC, Van Der Zee AGJ, Van Doorn HC, Van Der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational study on sentinel nodes in vulvar cancer (GROINSS-V) i. Gynecol Oncol. 2016;140(1):8–14.

    Article  Google Scholar 

  133. Aragona AM, Soderini AH, Cuneo NA. Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence. J Gynecol Oncol. 2014;25(4):272–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Kellas-Śleczka S, Białas B, Fijałkowski M, Wojcieszek P, Szlag M, Cholewka A, et al. Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer. J Contemp Brachytherapy. 2016;8(1):32–40.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Natesan D, Hong JC, Foote J, Sosa JA, Havrilesky L, Chino J. Primary versus preoperative radiation for locally advanced vulvar cancer. Int J Gynecol Cancer. 2017;27(4):794–804.

    Article  PubMed  Google Scholar 

  136. Gill BS, Bernard ME, Lin JF, Balasubramani GK, Rajagopalan MS, Sukumvanich P, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol. 2015;137(3):365–72.

    Article  PubMed  Google Scholar 

  137. Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017;27(4):832–7.

    Article  PubMed  Google Scholar 

  138. Cao H, Wang S, Zhang Z, Lou J. Prognostic value of overexpressed p16INK4a in vulvar cancer: a meta-analysis. PLoS One. 2016;11(3):e0152459.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  139. Tringler B, Grimm C, Dudek G, Zeillinger R, Tempfer C, Speiser P, et al. p16INK4a expression in invasive vulvar squamous cell carcinoma. Appl Immunohistochem Mol Morphol. 2007;15(3):279–83.

    Article  CAS  PubMed  Google Scholar 

  140. Dong F, Kojiro S, Borger DR, Growdon WB, Oliva E. Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR). Am J Surg Pathol. 2015;39(8):1045–53.

    Article  PubMed  Google Scholar 

  141. Rakislova N, Saco A, Sierra A, del Pino M, Ordi J. Role of human papillomavirus in vulvar cancer. Adv Anat Pathol. 2017;24(4):201–14.

    Article  PubMed  Google Scholar 

  142. Moscicki A-B, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, et al. Screening for anal cancer in women. J Low Genit Tract Dis. 2015;19:S26–41.

    Article  PubMed Central  Google Scholar 

  143. Acevedo-Fontánez AI, Suárez E, Torres Cintrón CR, Ortiz AP. Risk of anal cancer in women with a human papillomavirus–related gynecological neoplasm. J Low Genit Tract Dis. 2018;22(3):225–30.

    Article  PubMed  Google Scholar 

  144. Hillman RJ, Cuming T, Darragh T, Nathan M, Berry-Lawthorn M, Goldstone S, et al. 2016 IANS International guidelines for practice standards in the detection of anal cancer precursors. J Low Genit Tract Dis. 2016;20(4):283–91.

    Article  PubMed  Google Scholar 

  145. Nielsen A, Munk C, Kjaer SK. Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer. 2012;130(5):1168–73.

    Article  CAS  PubMed  Google Scholar 

  146. Key statistics for anal cancer [Internet]. https://www.cancer.org/cancer/anal-cancer/about/what-is-key-statistics.html.

  147. Vokes EE, Agrawal N, Seiwert TY. HPV-associated head and neck cancer. J Natl Cancer Inst. 2015;107(12):djv344.

    Article  PubMed  CAS  Google Scholar 

  148. Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319–31.

    Article  CAS  PubMed  Google Scholar 

  149. Hübbers CU, Akgül B. HPV and cancer of the oral cavity. Virulence. 2015;6(3):244–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  150. O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440–51.

    Article  PubMed  Google Scholar 

  151. Ortiz AP, González D, Vivaldi-Oliver J, Castañeda M, Rivera V, Díaz E, et al. Periodontitis and oral human papillomavirus infection among hispanic adults. Papillomavirus Res. 2018;5:128–33.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Woo S-B, Cashman EC, Lerman MA. Human papillomavirus-associated oral intraepithelial neoplasia. Mod Pathol. 2013;26(10):1288–97.

    Article  CAS  PubMed  Google Scholar 

  153. Gipson BJ, Robbins HA, Fakhry C, D’Souza G. Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer. Oral Oncol. 2018;77:52–6.

    Article  PubMed  Google Scholar 

  154. Chan PKS, Chang AR, Yu MY, Li W-H, Chan MYM, Yeung ACM, et al. Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. Int J Cancer. 2010;126(1):297–301.

    Article  CAS  PubMed  Google Scholar 

  155. Key statistics for cervical cancer [Internet]. https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html.

  156. Watson AJM, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg. 2006;76(8):715–7.

    Article  PubMed  Google Scholar 

  157. Scholefield JH, Castle MT, Watson NFS. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg. 2005;92(9):1133–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital Lusíadas Porto, Porto, Portugal

    Pedro Vieira-Baptista

  2. Lower Genital Tract Unit, Centro Hospitalar de São João, Porto, Portugal

    Pedro Vieira-Baptista

  3. Department of Obstetrics and Gynecology, Sant’Anna Hospital, University of Torino, Turin, Italy

    Mario Preti

  4. Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya and Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel

    Jacob Bornstein

Authors
  1. Pedro Vieira-Baptista
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Preti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacob Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Zaragoza Facultad de Medicina, Zaragoza, Spain

    Faustino R. Pérez-López

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vieira-Baptista, P., Preti, M., Bornstein, J. (2019). Human Papillomavirus Infection and Cancer Risk in Peri- and Postmenopausal Women. In: Pérez-López, F. (eds) Postmenopausal Diseases and Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-13936-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13936-0_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13935-3

  • Online ISBN: 978-3-030-13936-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation